Nuance Investments LLC Has $166.07 Million Position in Henry Schein, Inc. (NASDAQ:HSIC)

Nuance Investments LLC grew its position in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 22.3% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 2,278,081 shares of the company’s stock after buying an additional 414,748 shares during the quarter. Henry Schein makes up about 5.6% of Nuance Investments LLC’s investment portfolio, making the stock its 3rd biggest position. Nuance Investments LLC owned 1.80% of Henry Schein worth $166,072,000 at the end of the most recent reporting period.

Several other hedge funds also recently modified their holdings of HSIC. Vanguard Group Inc. increased its holdings in Henry Schein by 1.7% during the 1st quarter. Vanguard Group Inc. now owns 15,432,001 shares of the company’s stock valued at $1,165,425,000 after purchasing an additional 260,537 shares in the last quarter. American Century Companies Inc. lifted its position in Henry Schein by 3.1% during the 2nd quarter. American Century Companies Inc. now owns 5,484,286 shares of the company’s stock worth $351,543,000 after buying an additional 162,477 shares in the last quarter. Swedbank AB bought a new stake in Henry Schein during the 1st quarter worth about $215,998,000. Burgundy Asset Management Ltd. increased its position in Henry Schein by 1.0% in the 2nd quarter. Burgundy Asset Management Ltd. now owns 1,640,379 shares of the company’s stock valued at $105,148,000 after acquiring an additional 16,476 shares in the last quarter. Finally, Dimensional Fund Advisors LP lifted its position in shares of Henry Schein by 10.1% during the second quarter. Dimensional Fund Advisors LP now owns 1,634,384 shares of the company’s stock worth $104,764,000 after purchasing an additional 149,517 shares in the last quarter. Institutional investors and hedge funds own 96.62% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently weighed in on HSIC shares. Robert W. Baird dropped their target price on Henry Schein from $92.00 to $82.00 and set an “outperform” rating for the company in a research report on Wednesday, August 7th. UBS Group dropped their price target on shares of Henry Schein from $75.00 to $72.00 and set a “neutral” rating for the company in a research note on Wednesday, August 7th. JPMorgan Chase & Co. reduced their price objective on shares of Henry Schein from $88.00 to $80.00 and set an “overweight” rating on the stock in a research note on Monday, August 12th. StockNews.com raised shares of Henry Schein from a “sell” rating to a “hold” rating in a report on Thursday, November 7th. Finally, Evercore ISI increased their price target on Henry Schein from $70.00 to $74.00 and gave the company an “in-line” rating in a research note on Tuesday, October 8th. Six research analysts have rated the stock with a hold rating, five have given a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $78.89.

Henry Schein Trading Up 1.3 %

Shares of NASDAQ:HSIC opened at $74.84 on Wednesday. The firm has a market cap of $9.33 billion, a price-to-earnings ratio of 30.80, a PEG ratio of 1.97 and a beta of 0.87. Henry Schein, Inc. has a 12 month low of $63.67 and a 12 month high of $82.63. The company’s fifty day simple moving average is $70.55 and its 200 day simple moving average is $69.66. The company has a quick ratio of 0.82, a current ratio of 1.42 and a debt-to-equity ratio of 0.46.

Henry Schein (NASDAQ:HSIC) last issued its quarterly earnings results on Tuesday, November 5th. The company reported $1.22 EPS for the quarter, beating analysts’ consensus estimates of $1.17 by $0.05. The company had revenue of $3.17 billion for the quarter, compared to analyst estimates of $3.24 billion. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The company’s quarterly revenue was up .4% compared to the same quarter last year. During the same period in the previous year, the company posted $1.32 earnings per share. As a group, research analysts forecast that Henry Schein, Inc. will post 4.78 EPS for the current fiscal year.

Insider Transactions at Henry Schein

In related news, SVP Lorelei Mcglynn sold 21,035 shares of Henry Schein stock in a transaction dated Friday, September 6th. The stock was sold at an average price of $69.30, for a total value of $1,457,725.50. Following the sale, the senior vice president now owns 71,833 shares of the company’s stock, valued at approximately $4,978,026.90. The trade was a 22.65 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 1.14% of the company’s stock.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.